Showing results (121-130 of 205) with videos related to

Sort By:
Pageof 21
Neurology|October 23, 2020
Topographic Distribution of Amyloid-β, Tau, and Atrophy in Patients With Behavioral/Dysexecutive Alzheimer DiseaseJoseph Therriault, Tharick A Pascoal, Melissa Savard, et al.
Molecular Neurodegeneration|December 12, 2022
Antibody-free measurement of cerebrospinal fluid tau phosphorylation across the Alzheimer's disease continuumJohan Gobom, Andréa L Benedet, Niklas Mattsson-Carlgren, et al.
Alzheimer'S Research & Therapy|July 21, 2024
Hormone therapy is associated with lower Alzheimer's disease tau biomarkers in post-menopausal females -evidence from two independent cohortsYi-Ting Wang, Joseph Therriault, Cécile Tissot, et al.
Molecular Neurodegeneration|May 6, 2025
Cerebrospinal fluid proteome profiling across the Alzheimer's disease continuum: a step towards solving the equation for 'X'Sophia Weiner, Mathias Sauer, Laia Montoliu-Gaya, et al.
Alzheimer'S & Dementia (New York, N. Y.)|March 21, 2022
A three-range approach enhances the prognostic utility of CSF biomarkers in Alzheimer's diseaseWagner S Brum, Marco Antônio de Bastiani, Andrei Bieger, et al.
Nature Communications|June 6, 2019
Aβ-induced vulnerability propagates via the brain's default mode networkTharick A Pascoal, Sulantha Mathotaarachchi, Min Su Kang, et al.
Nature Aging|August 23, 2025
Plasma tau biomarkers for biological staging of Alzheimer's diseaseLaia Montoliu-Gaya, Gemma Salvadó, Joseph Therriault, et al.
Ebiomedicine|February 14, 2022
Cerebrospinal fluid p-tau231 as an early indicator of emerging pathology in Alzheimer's diseaseNicholas J Ashton, Andréa L Benedet, Tharick A Pascoal, et al.
Nature Communications|March 15, 2024
A blood-based biomarker workflow for optimal tau-PET referral in memory clinic settingsWagner S Brum, Nicholas C Cullen, Joseph Therriault, et al.
Pageof 21